Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Profiles of Contextual Risk at Birth and Adolescent Substance Use.

Parra GR, Smith GL, Mason WA, Savolainen J, Chmelka MB, Miettunen J, Järvelin MR, Moilanen I, Veijola J.

J Child Fam Stud. 2018 Mar;27(3):717-724. doi: 10.1007/s10826-017-0935-x. Epub 2017 Nov 17.

PMID:
29861618
2.

Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants.

Zhou A, Taylor AE, Karhunen V, Zhan Y, Rovio SP, Lahti J, Sjögren P, Byberg L, Lyall DM, Auvinen J, Lehtimäki T, Kähönen M, Hutri-Kähönen N, Perälä MM, Michaëlsson K, Mahajan A, Lind L, Power C, Eriksson JG, Raitakari OT, Hägg S, Pedersen NL, Veijola J, Järvelin MR, Munafò MR, Ingelsson E, Llewellyn DJ, Hyppönen E.

Sci Rep. 2018 May 14;8(1):7526. doi: 10.1038/s41598-018-25919-2.

3.

Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women.

Liuhanen J, Suvisaari J, Kajantie E, Miettunen J, Sarin AP, Järvelin MR, Lönnqvist J, Veijola J, Paunio T.

Psychiatry Res. 2018 Jan;259:148-153. doi: 10.1016/j.psychres.2017.10.020. Epub 2017 Oct 9.

PMID:
29049906
4.

Vitamin D and cognitive function: A Mendelian randomisation study.

Maddock J, Zhou A, Cavadino A, Kuźma E, Bao Y, Smart MC, Saum KU, Schöttker B, Engmann J, Kjærgaard M, Karhunen V, Zhan Y, Lehtimäki T, Rovio SP, Byberg L, Lahti J, Marques-Vidal P, Sen A, Perna L, Schirmer H, Singh-Manoux A, Auvinen J, Hutri-Kähönen N, Kähönen M, Kilander L, Räikkönen K, Melhus H, Ingelsson E, Guessous I, Petrovic KE, Schmidt H, Schmidt R, Vollenweider P, Lind L, Eriksson JG, Michaëlsson K, Raitakari OT, Hägg S, Pedersen NL, Herzig KH, Järvelin MR, Veijola J, Kivimaki M, Jorde R, Brenner H, Kumari M, Power C, Llewellyn DJ, Hyppönen E.

Sci Rep. 2017 Oct 16;7(1):13230. doi: 10.1038/s41598-017-13189-3.

5.

Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.

Huhtaniska S, Jääskeläinen E, Heikka T, Moilanen JS, Lehtiniemi H, Tohka J, Manjón JV, Coupé P, Björnholm L, Koponen H, Veijola J, Isohanni M, Kiviniemi V, Murray GK, Miettunen J.

Psychiatry Res Neuroimaging. 2017 Aug 30;266:73-82. doi: 10.1016/j.pscychresns.2017.05.009. Epub 2017 May 20.

PMID:
28618327
6.

Early adversity and brain response to faces in young adulthood.

Lieslehto J, Kiviniemi V, Mäki P, Koivukangas J, Nordström T, Miettunen J, Barnett JH, Jones PB, Murray GK, Moilanen I; IMAGEN, Paus T, Veijola J.

Hum Brain Mapp. 2017 Sep;38(9):4470-4478. doi: 10.1002/hbm.23674. Epub 2017 Jun 14.

PMID:
28612935
7.

Cytokine data obtained from synovial stromal cells of patients with rheumatoid arthritis or osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

Data Brief. 2017 Apr 29;12:593-602. doi: 10.1016/j.dib.2017.04.041. eCollection 2017 Jun.

8.

Genome-Wide Association Study of Psychosis Proneness in the Finnish Population.

Ortega-Alonso A, Ekelund J, Sarin AP, Miettunen J, Veijola J, Järvelin MR, Hennah W.

Schizophr Bull. 2017 Oct 21;43(6):1304-1314. doi: 10.1093/schbul/sbx006.

PMID:
28525603
9.

Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.

Huhtaniska S, Jääskeläinen E, Hirvonen N, Remes J, Murray GK, Veijola J, Isohanni M, Miettunen J.

Hum Psychopharmacol. 2017 Mar;32(2). doi: 10.1002/hup.2574. Review.

PMID:
28370309
10.

Structural properties of the human corpus callosum: Multimodal assessment and sex differences.

Björnholm L, Nikkinen J, Kiviniemi V, Nordström T, Niemelä S, Drakesmith M, Evans JC, Pike GB, Veijola J, Paus T.

Neuroimage. 2017 May 15;152:108-118. doi: 10.1016/j.neuroimage.2017.02.056. Epub 2017 Feb 22.

PMID:
28254453
11.

1,25(OH)2D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients with rheumatoid arthritis and osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

J Steroid Biochem Mol Biol. 2017 Oct;173:13-22. doi: 10.1016/j.jsbmb.2017.01.017. Epub 2017 Feb 3.

PMID:
28167299
12.

The Effect of Gray Matter ICA and Coefficient of Variation Mapping of BOLD Data on the Detection of Functional Connectivity Changes in Alzheimer's Disease and bvFTD.

Tuovinen T, Rytty R, Moilanen V, Abou Elseoud A, Veijola J, Remes AM, Kiviniemi VJ.

Front Hum Neurosci. 2017 Jan 9;10:680. doi: 10.3389/fnhum.2016.00680. eCollection 2016.

13.

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.

Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma VM, Sawazaki-Calone I, Macedo CC, Bloigu R, Coletta RD, Salo T.

Br J Cancer. 2017 Feb 28;116(5):640-648. doi: 10.1038/bjc.2016.455. Epub 2017 Jan 17.

14.

Association between family history of psychiatric disorders and long-term outcome in schizophrenia - The Northern Finland Birth Cohort 1966 study.

Käkelä J, Marttila R, Keskinen E, Veijola J, Isohanni M, Koivumaa-Honkanen H, Haapea M, Jääskeläinen E, Miettunen J.

Psychiatry Res. 2017 Mar;249:16-22. doi: 10.1016/j.psychres.2016.12.040. Epub 2016 Dec 27.

PMID:
28063393
15.

Smoking in pregnancy, adolescent mental health and cognitive performance in young adult offspring: results from a matched sample within a Finnish cohort.

Ramsay H, Barnett JH, Murray GK, Mäki P, Hurtig T, Nordström T, Miettunen J, Kiviniemi V, Niemelä S, Pausova Z, Paus T, Veijola J.

BMC Psychiatry. 2016 Dec 1;16(1):430.

16.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21. Erratum in: Nat Genet. 2017 Sep 27;49(10 ):1558. Nat Genet. 2017 Mar 30;49(4):651.

17.

Longitudinal Pathways from Cumulative Contextual Risk at Birth to School Functioning in Adolescence: Analysis of Mediation Effects and Gender Moderation.

January SA, Mason WA, Savolainen J, Solomon S, Chmelka MB, Miettunen J, Veijola J, Moilanen I, Taanila A, Järvelin MR.

J Youth Adolesc. 2017 Jan;46(1):180-196. doi: 10.1007/s10964-016-0560-9. Epub 2016 Sep 24.

18.

Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study.

Metcalf SA, Jones PB, Nordstrom T, Timonen M, Mäki P, Miettunen J, Jääskeläinen E, Järvelin MR, Stochl J, Murray GK, Veijola J, Khandaker GM.

Brain Behav Immun. 2017 Jan;59:253-259. doi: 10.1016/j.bbi.2016.09.008. Epub 2016 Sep 10.

19.

Body mass index and brain white matter structure in young adults at risk for psychosis - The Oulu Brain and Mind Study.

Koivukangas J, Björnholm L, Tervonen O, Miettunen J, Nordström T, Kiviniemi V, Mäki P, Mukkala S, Moilanen I, Barnett JH, Jones PB, Nikkinen J, Veijola J.

Psychiatry Res Neuroimaging. 2016 Aug 30;254:169-76. doi: 10.1016/j.pscychresns.2016.06.016. Epub 2016 Jul 6.

PMID:
27474847
20.

The effect of prenatal smoking exposure on daily smoking among teenage offspring.

Niemelä S, Räisänen A, Koskela J, Taanila A, Miettunen J, Ramsay H, Veijola J.

Addiction. 2017 Jan;112(1):134-143. doi: 10.1111/add.13533. Epub 2016 Sep 21.

PMID:
27444807
21.

Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966.

Moilanen JM, Haapea M, Jääskeläinen E, Veijola JM, Isohanni MK, Koponen HJ, Miettunen J.

Eur Psychiatry. 2016 Aug;36:7-14. doi: 10.1016/j.eurpsy.2016.03.002. Epub 2016 Jun 13.

PMID:
27311102
22.

A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986.

Filatova S, Marttila R, Koivumaa-Honkanen H, Nordström T, Veijola J, Mäki P, Khandaker GM, Isohanni M, Jääskeläinen E, Moilanen K, Miettunen J.

Epidemiol Psychiatr Sci. 2017 Jun;26(3):314-324. doi: 10.1017/S2045796016000123. Epub 2016 Mar 28.

PMID:
27018550
23.

Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.

Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J, Suvisaari J, Chheda H, Blackwood D, Breen G, Pietiläinen O, Gerety SS, Ayub M, Blyth M, Cole T, Collier D, Coomber EL, Craddock N, Daly MJ, Danesh J, DiForti M, Foster A, Freimer NB, Geschwind D, Johnstone M, Joss S, Kirov G, Körkkö J, Kuismin O, Holmans P, Hultman CM, Iyegbe C, Lönnqvist J, Männikkö M, McCarroll SA, McGuffin P, McIntosh AM, McQuillin A, Moilanen JS, Moore C, Murray RM, Newbury-Ecob R, Ouwehand W, Paunio T, Prigmore E, Rees E, Roberts D, Sambrook J, Sklar P, St Clair D, Veijola J, Walters JT, Williams H; Swedish Schizophrenia Study; INTERVAL Study; DDD Study; UK10 K Consortium, Sullivan PF, Hurles ME, O'Donovan MC, Palotie A, Owen MJ, Barrett JC.

Nat Neurosci. 2016 Apr;19(4):571-7. doi: 10.1038/nn.4267. Epub 2016 Mar 14.

PMID:
26974950
24.

Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.

Gaciarz A, Veijola J, Uchida Y, Saaranen MJ, Wang C, Hörkkö S, Ruddock LW.

Microb Cell Fact. 2016 Jan 25;15:22. doi: 10.1186/s12934-016-0419-5.

25.

Brain structural changes in women and men during midlife.

Guo JY, Isohanni M, Miettunen J, Jääskeläinen E, Kiviniemi V, Nikkinen J, Remes J, Huhtaniska S, Veijola J, Jones PB, Murray GK.

Neurosci Lett. 2016 Feb 26;615:107-12. doi: 10.1016/j.neulet.2016.01.007. Epub 2016 Jan 8.

26.

Predictors of Long-Term Change in Adult Cognitive Performance: Systematic Review and Data from the Northern Finland Birth Cohort 1966.

Rannikko I, Jääskeläinen E, Miettunen J, Ahmed AO, Veijola J, Remes AM, Murray GK, Husa AP, Järvelin MR, Isohanni M, Haapea M.

Clin Neuropsychol. 2016;30(1):17-50. doi: 10.1080/13854046.2015.1128000. Epub 2016 Jan 6. Review.

27.

Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.

Kerkelä E, Laitinen A, Räbinä J, Valkonen S, Takatalo M, Larjo A, Veijola J, Lampinen M, Siljander P, Lehenkari P, Alfthan K, Laitinen S.

Stem Cells. 2016 Mar;34(3):781-90. doi: 10.1002/stem.2280. Epub 2016 Jan 26.

28.

Seasonal variation in affective and other clinical symptoms among high-risk families for bipolar disorders in an Arctic population.

Pirkola S, Eriksen HA, Partonen T, Kieseppä T, Veijola J, Jääskeläinen E, Mylläri-Figuerola EM, Salo PM, Paunio T.

Int J Circumpolar Health. 2015 Nov 19;74:29671. doi: 10.3402/ijch.v74.29671. eCollection 2015.

29.

Cerebellar activity in young people with familial risk for psychosis--The Oulu Brain and Mind Study.

Jukuri T, Kiviniemi V, Nikkinen J, Miettunen J, Mäki P, Mukkala S, Koivukangas J, Nordström T, Moilanen I, Barnett JH, Jones PB, Murray GK, Veijola J.

Schizophr Res. 2015 Dec;169(1-3):46-53. doi: 10.1016/j.schres.2015.10.010. Epub 2015 Oct 30.

PMID:
26527249
30.

Interactions between uncoupling protein 2 gene polymorphisms, obesity and alcohol intake on liver function: a large meta-analysed population-based study.

Vimaleswaran KS, Cavadino A, Verweij N, Nolte IM, Mateo Leach I; LifeLines Cohort Study, Auvinen J, Veijola J, Elliott P, Penninx BW, Snieder H, Järvelin MR, van der Harst P, Cohen RD, Boucher BJ, Hyppönen E.

Eur J Endocrinol. 2015 Dec;173(6):863-72. doi: 10.1530/EJE-15-0839.

31.

Neurocognition as a predictor of outcome in schizophrenia in the Northern Finland Birth Cohort 1966.

Juola P, Miettunen J, Salo H, Murray GK, Ahmed AO, Veijola J, Isohanni M, Jääskeläinen E.

Schizophr Res Cogn. 2015 Sep 21;2(3):113-119. doi: 10.1016/j.scog.2015.07.001. eCollection 2015 Sep.

32.

Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Rannikko I, Murray GK, Juola P, Salo H, Haapea M, Miettunen J, Veijola J, Barnett JH, Husa AP, Jones PB, Järvelin MR, Isohanni M, Jääskeläinen E.

Schizophr Res Cogn. 2015 Sep 9;2(3):120-126. doi: 10.1016/j.scog.2015.08.001. eCollection 2015 Sep.

33.

Brain structural deficits and working memory fMRI dysfunction in young adults who were diagnosed with ADHD in adolescence.

Roman-Urrestarazu A, Lindholm P, Moilanen I, Kiviniemi V, Miettunen J, Jääskeläinen E, Mäki P, Hurtig T, Ebeling H, Barnett JH, Nikkinen J, Suckling J, Jones PB, Veijola J, Murray GK.

Eur Child Adolesc Psychiatry. 2016 May;25(5):529-38. doi: 10.1007/s00787-015-0755-8. Epub 2015 Aug 26.

34.

White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study.

Koivukangas J, Björnholm L, Tervonen O, Miettunen J, Nordström T, Kiviniemi V, Mäki P, Jääskeläinen E, Mukkala S, Moilanen I, Barnett JH, Jones PB, Nikkinen J, Veijola J.

Psychiatry Res. 2015 Sep 30;233(3):388-93. doi: 10.1016/j.pscychresns.2015.06.015. Epub 2015 Jul 2.

PMID:
26231121
35.

Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.

Guo JY, Huhtaniska S, Miettunen J, Jääskeläinen E, Kiviniemi V, Nikkinen J, Moilanen J, Haapea M, Mäki P, Jones PB, Veijola J, Isohanni M, Murray GK.

Schizophr Res. 2015 Oct;168(1-2):297-304. doi: 10.1016/j.schres.2015.06.016. Epub 2015 Jul 16.

36.

Rsu1 regulates ethanol consumption in Drosophila and humans.

Ojelade SA, Jia T, Rodan AR, Chenyang T, Kadrmas JL, Cattrell A, Ruggeri B, Charoen P, Lemaitre H, Banaschewski T, Büchel C, Bokde AL, Carvalho F, Conrod PJ, Flor H, Frouin V, Gallinat J, Garavan H, Gowland PA, Heinz A, Ittermann B, Lathrop M, Lubbe S, Martinot JL, Paus T, Smolka MN, Spanagel R, O'Reilly PF, Laitinen J, Veijola JM, Feng J, Desrivières S, Jarvelin MR; IMAGEN Consortium, Schumann G, Rothenfluh A.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4085-93. doi: 10.1073/pnas.1417222112. Epub 2015 Jul 13.

37.

Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.

Rannikko I, Haapea M, Miettunen J, Veijola J, Murray GK, Barnett JH, Husa AP, Jones PB, Isohanni M, Jääskeläinen E.

Psychiatry Res. 2015 Aug 30;228(3):671-9. doi: 10.1016/j.psychres.2015.04.048. Epub 2015 Jun 16.

PMID:
26168931
38.

Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.

Ramsay H, Barnett JH, Miettunen J, Mukkala S, Mäki P, Liuhanen J, Murray GK, Jarvelin MR, Ollila H, Paunio T, Veijola J.

PLoS One. 2015 Jun 26;10(6):e0127602. doi: 10.1371/journal.pone.0127602. eCollection 2015.

39.

Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.

Moilanen J, Huhtaniska S, Haapea M, Jääskeläinen E, Veijola J, Isohanni M, Koponen H, Miettunen J.

Eur Psychiatry. 2015 Jul;30(5):598-605. doi: 10.1016/j.eurpsy.2015.02.009. Epub 2015 Mar 16.

PMID:
25791180
40.

Aberrant Functional Connectivity in the Default Mode and Central Executive Networks in Subjects with Schizophrenia - A Whole-Brain Resting-State ICA Study.

Littow H, Huossa V, Karjalainen S, Jääskeläinen E, Haapea M, Miettunen J, Tervonen O, Isohanni M, Nikkinen J, Veijola J, Murray G, Kiviniemi VJ.

Front Psychiatry. 2015 Feb 26;6:26. doi: 10.3389/fpsyt.2015.00026. eCollection 2015.

41.

Enhancing sense of coherence via early intervention among depressed occupational health care clients.

Valtonen M, Raiskila T, Veijola J, Läksy K, Kauhanen ML, Kiuttu J, Joukamaa M, Hintsa T, Tuulio-Henriksson A.

Nord J Psychiatry. 2015;69(7):515-22. doi: 10.3109/08039488.2015.1011230. Epub 2015 Mar 5.

PMID:
25739527
42.

Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study.

Pulkkinen J, Nikkinen J, Kiviniemi V, Mäki P, Miettunen J, Koivukangas J, Mukkala S, Nordström T, Barnett JH, Jones PB, Moilanen I, Murray GK, Veijola J.

Schizophr Res. 2015 May;164(1-3):242-9. doi: 10.1016/j.schres.2015.01.039. Epub 2015 Feb 18.

PMID:
25703807
43.

Seasonal variation in affective and other clinical symptoms among high-risk families for bipolar disorders in an Arctic population.

Pirkola S, Eriksen HA, Partonen T, Kieseppä T, Veijola J, Jääskeläinen E, Mylläri-Figuerola EM, Salo PM, Paunio T.

Int J Circumpolar Health. 2015 Jan;74(1):29671. doi: 10.3402/ijch.v74.29671.

PMID:
28417785
44.

Central executive network in young people with familial risk for psychosis--the Oulu Brain and Mind Study.

Jukuri T, Kiviniemi V, Nikkinen J, Miettunen J, Mäki P, Mukkala S, Koivukangas J, Nordström T, Parkkisenniemi J, Moilanen I, Barnett JH, Jones PB, Murray GK, Veijola J.

Schizophr Res. 2015 Feb;161(2-3):177-83. doi: 10.1016/j.schres.2014.11.003. Epub 2014 Nov 22.

PMID:
25468181
45.

Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium.

Taylor AE, Fluharty ME, Bjørngaard JH, Gabrielsen ME, Skorpen F, Marioni RE, Campbell A, Engmann J, Mirza SS, Loukola A, Laatikainen T, Partonen T, Kaakinen M, Ducci F, Cavadino A, Husemoen LL, Ahluwalia TS, Jacobsen RK, Skaaby T, Ebstrup JF, Mortensen EL, Minica CC, Vink JM, Willemsen G, Marques-Vidal P, Dale CE, Amuzu A, Lennon LT, Lahti J, Palotie A, Räikkönen K, Wong A, Paternoster L, Wong AP, Horwood LJ, Murphy M, Johnstone EC, Kennedy MA, Pausova Z, Paus T, Ben-Shlomo Y, Nohr EA, Kuh D, Kivimaki M, Eriksson JG, Morris RW, Casas JP, Preisig M, Boomsma DI, Linneberg A, Power C, Hyppönen E, Veijola J, Jarvelin MR, Korhonen T, Tiemeier H, Kumari M, Porteous DJ, Hayward C, Romundstad PR, Smith GD, Munafò MR.

BMJ Open. 2014 Oct 7;4(10):e006141. doi: 10.1136/bmjopen-2014-006141.

46.

DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study.

Bode MK, Lindholm P, Kiviniemi V, Moilanen I, Ebeling H, Veijola J, Miettunen J, Hurtig T, Nordström T, Starck T, Remes J, Tervonen O, Nikkinen J.

Acta Radiol. 2015 Aug;56(8):990-6. doi: 10.1177/0284185114545147. Epub 2014 Sep 2.

PMID:
25182805
47.

The association of genotype-based inbreeding coefficient with a range of physical and psychological human traits.

Verweij KJ, Abdellaoui A, Veijola J, Sebert S, Koiranen M, Keller MC, Järvelin MR, Zietsch BP.

PLoS One. 2014 Jul 25;9(7):e103102. doi: 10.1371/journal.pone.0103102. eCollection 2014.

48.

Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.

Veijola J, Guo JY, Moilanen JS, Jääskeläinen E, Miettunen J, Kyllönen M, Haapea M, Huhtaniska S, Alaräisänen A, Mäki P, Kiviniemi V, Nikkinen J, Starck T, Remes JJ, Tanskanen P, Tervonen O, Wink AM, Kehagia A, Suckling J, Kobayashi H, Barnett JH, Barnes A, Koponen HJ, Jones PB, Isohanni M, Murray GK.

PLoS One. 2014 Jul 18;9(7):e101689. doi: 10.1371/journal.pone.0101689. eCollection 2014.

49.

Maternal cigarette smoking during pregnancy predicts drug use via externalizing behavior in two community-based samples of adolescents.

Lotfipour S, Ferguson E, Leonard G, Miettunen J, Perron M, Pike GB, Richer L, Séguin JR, Veillette S, Jarvelin MR, Moilanen I, Mäki P, Nordström T, Pausova Z, Veijola J, Paus T.

Addiction. 2014 Oct;109(10):1718-29. doi: 10.1111/add.12665. Epub 2014 Jul 21.

PMID:
24942256
50.

Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1.

Ramos A, Rodríguez-Seoane C, Rosa I, Trossbach SV, Ortega-Alonso A, Tomppo L, Ekelund J, Veijola J, Järvelin MR, Alonso J, Veiga S, Sawa A, Hennah W, García A, Korth C, Requena JR.

Hum Mol Genet. 2014 Nov 15;23(22):5859-65. doi: 10.1093/hmg/ddu303. Epub 2014 Jun 16.

Supplemental Content

Loading ...
Support Center